FAM phosphoramidite, 6-isomer
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
D5160
/ Easily soluble lyophilised form in 8 mL septum
|
250 mg |
$105
|
in stock | |
F5160
/ Easily soluble lyophilised form in 30 mL septum
|
1 g |
$167
|
in stock | |
G5160 | 5 g |
$740
|
in stock | |
H5160 | 10 g |
$970
|
in stock | |
K5160 | 50 g |
please inquire
|
in stock | |
L5160 | 100 g |
please inquire
|
in stock |
FAM (fluorescein) phosphoramidite 6-isomer is specifically designed for incorporation at the 5′-end of oligonucleotides, which is essential for many biochemical assays and applications. It is primarily utilized for labeling oligonucleotides, enhancing their visibility in various assays such as PCR, sequencing and hybridization studies. It is commonly employed in real-time PCR assays where fluorescent signals are monitored during amplification. The incorporation of FAM at the 5′-end allows for efficient monitoring of the reaction progress through fluorescence.
FAM emits fluorescence with a maximal emission wavelength around 517 nm, which is ideal for various detection methods. It can be quenched by agents like DusQ 1 or DABCYL, allowing for applications in assays that require precise control over fluorescence signals.
Internal sequence additions can be achieved using modified nucleotides such as FAM-dT phosphoramidite, allowing for flexible design of probes with multiple fluorescent tags while maintaining effective spacing. However, it is essential to include spacers between the labels to prevent self-quenching of fluorescence signals, which can occur due to close proximity.
The dye soluble in common organic solvents such as acetonitrile, DCM, DMF, DMSO. Once conjugated to biomolecules, the resulting FAM conjugates can be used in aqueous applications.
Product in action
FAM absorbance and emission spectra

Customers also purchased with this product
Phosphate CPG 1000 solid support
Phosphate modifier CPG for the solid phase synthesis of long (up to 120mer) oligonucleotides containing 3 prime phosphate modification.JOE phosphoramidite, 5-isomer
JOE phosphoramidite is a xanthene dye phosphoramidite used in oligo synthesis. Its absorption and emission spectra are located between the FAM and TAMRA channels.get free express delivery
endo-BCN CE-phosphoramidite
BCN-containing phosphoramidite for the synthesis of oligonucleotides and their labeling using copper-free click reactions.get free express delivery
General properties
Appearance: | off-white solid |
Molecular weight: | 843.94 |
CAS number: | 204697-37-0 |
Molecular formula: | C46H58N3O10P |
Solubility: | acetonitrile, DCM, DMF, DMSO |
Quality control: | NMR 1H and 31P, HPLC-MS (95+%), isomeric purity > 97% |
Storage conditions: | Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 492 |
ε, L⋅mol−1⋅cm−1: | 74000 |
Emission maximum, nm: | 517 |
Fluorescence quantum yield: | 0.93 |
CF260: | 0.22 |
CF280: | 0.17 |
Oligo synthesis details
Diluent: | acetonitrile |
Coupling conditions: | coupling time 10 min |
Cleavage conditions: | ammonia, 2 h at room temperature |
Deprotection conditions: | identical to protected nucleobases; when AMA is used, deblock with ammonia alone for 30 min, then add methylamine |
Product citations
- Zharkov, T.D.; Mironova, E.M.; Markov, O.V.; Zhukov, S.A.; Khodyreva, S.N.; Kupryushkin, M.S. Fork- and Comb-like Lipophilic Structures: Different Chemical Approaches to the Synthesis of Oligonucleotides with Multiple Dodecyl Residues. International Journal of Molecular Sciences, 2023, 24(19), 14637. doi: 10.3390/ijms241914637
- Bulgakova, A.; Chubarov, A.; Dmitrienko, E. Magnetic Nylon 6 Nanocomposites for the Microextraction of Nucleic Acids from Biological Samples. Magnetochemistry, 2022, 8(8), 85. doi: 10.3390/magnetochemistry8080085
- Stanton, J.-A.L.; O'Brien, R.; Hall, R.J.; Chernyavtseva, A.; Ha, H.J.; Jelley, L.; Mace, P.D.; Klenov, A.; Treece, J.M.; Fraser, J.D.; Clow, F.; Clarke, L.; Su, Y.; Kurup, H.M.; Filichev, V.V.; Rolleston, W.; Law, L.; Rendle, P.M.; Harris, L.D.; Wood, J.M.; Scully, T.W.; Ussher, J.E.; Grant, J.; Hore, T.A.; Moser, T.V.; Harfoot, R.; Lawley, B.; Quiñones-Mateu, M.E.; Collins, P.; Blaikie, R. Uncoupling Molecular Testing for SARS-CoV-2 From International Supply Chains. Frontiers in Public Health, 2022, 9, 808751. doi: 10.3389/fpubh.2021.808751
- Zhou, Z.; Liu, S.; Zhang, Y.; Yang, X.; Ma, Y.; Guan, Z.; Wu, Y.; Zhang, L.; Yang, Z. Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells. International Journal of Nanomedicine, 2017, 12, 7255–7272. doi: 10.2147/ijn.S136726
